2021
DOI: 10.3389/fimmu.2020.618402
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response

Abstract: Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87 days after the first positive test, 97 days after symptom onset. The subject did not have any associated rise in anti-Spike protein antibody titers or plasma neutralization activity, arguing against re-infection. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 16 publications
3
11
0
Order By: Relevance
“…Despite the increased T-cell response magnitudes observed in individuals from the prolonged group, it is possible that their T-cell responses may be less functional, therefore allowing a persistence of SARS-CoV-2 virus. This was previously observed in a single individual with prolonged symptoms, persistent PCR+ test results and an impaired IFNg T-cell response (61). This scenario, along with our findings, indicates that COVID-19 vaccination may provide therapeutic benefits to a subset of PASC patients (62).…”
Section: Magnitude Of Sars-cov-2-specific Immune Response Correlates To Symptom Durationsupporting
confidence: 86%
“…Despite the increased T-cell response magnitudes observed in individuals from the prolonged group, it is possible that their T-cell responses may be less functional, therefore allowing a persistence of SARS-CoV-2 virus. This was previously observed in a single individual with prolonged symptoms, persistent PCR+ test results and an impaired IFNg T-cell response (61). This scenario, along with our findings, indicates that COVID-19 vaccination may provide therapeutic benefits to a subset of PASC patients (62).…”
Section: Magnitude Of Sars-cov-2-specific Immune Response Correlates To Symptom Durationsupporting
confidence: 86%
“…It has recently been reported that prolonged viral shedding can be observed after immunosuppressive therapy for cancer [10]. Moreover, it was noted that a diminished CD8 + T-cell response, which is seen in people with frailty [11], correlates with prolonged viral shedding [12]. Therefore, frailty might explain the prolonged viral shedding in our case.…”
Section: Discussionsupporting
confidence: 52%
“…Although patients improved using CCR5 antagonists, the levels of these cytokines decreased but not to normal levels suggesting persistent cytokinemia following discharge from hospitals. In addition, studies including those from our laboratory, have suggested that PASC may be caused by persistent SARS-CoV-2 itself ( 5 ). Here, we sought to identify possible immunologic signatures of COVID-19 severity and to determine whether PASC might represent a distinct immunologic condition compared to Mild to Moderate (MM) or Severe COVID-19.…”
Section: Introductionmentioning
confidence: 99%